Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial)
Authors:
- 1 October 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 106 (12) , 1602-1610
Abstract
Background: A survival benefit of extensive intraoperative peritoneal lavage (EIPL) has been reported in patients with gastric cancer with positive peritoneal cytology. The hypothesis of this study was that EIPL may reduce peritoneal recurrence in patients with advanced gastric cancer who undergo surgery with curative intent. Methods: This was an open-label, multi-institutional, randomized, phase 3 trial to assess the effects of EIPL versus standard treatment after curative gastrectomy for resectable gastric cancer of T3 status or above. The primary endpoint was disease-free survival (DFS); secondary endpoints were overall survival, peritoneal recurrence-free survival and incidence of adverse events. Results: Between July 2011 and January 2014, 314 patients were enrolled from 15 institutions and 295 patients were analysed (145 and 150 in the EIPL and no-EIPL groups respectively). The 3-year DFS rate was 63·9 (95 per cent c.i. 55·5 to 71·2) per cent in the EIPL group and 59·7 (51·3 to 67·1) per cent in the control group (hazard ratio (HR) 0·81, 95 per cent c.i. 0·57 to 1·16; P = 0·249). The 3-year overall survival rate was 75·0 (67·1 to 81·3) per cent in the EIPL group and 73·7 (65·9 to 80·1) per cent in the control group (HR 0·91, 0·60 to 1·37; P = 0·634). Peritoneal recurrence-free survival was not significantly different between the two groups (HR 0·92, 0·62 to 1·36; P = 0·676). No intraoperative complications related to EIPL were observed. Conclusion: EIPL did not improve survival or peritoneal recurrence in patients who underwent gastrectomy for advanced gastric cancer. Registration number: 000005907 (http://www.umin.ac.jp/ctr/index.htm).Keywords
This publication has 23 references indexed in Scilit:
- A Randomized Phase III Trial Exploring the Prognostic Value of Extensive Intraoperative Peritoneal Lavage in Addition to Standard Treatment for Resectable Advanced Gastric Cancer: CCOG 1102 StudyJapanese Journal of Clinical Oncology, 2013
- Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registryGastric Cancer, 2012
- D2 lymphadenectomy can disseminate tumor cells into peritoneal cavity in patients with advanced gastric cancerNeoplasma, 2012
- Japanese classification of gastric carcinoma: 3rd English editionGastric Cancer, 2011
- Dissemination of Free Cancer Cells from the Gastric Lumen and from Perigastric Lymphovascular Pedicles during Radical Gastric Cancer SurgeryAnnals of Surgical Oncology, 2011
- Extensive Intraoperative Peritoneal Lavage as a Standard Prophylactic Strategy for Peritoneal Recurrence in Patients with Gastric CarcinomaAnnals of Surgery, 2009
- Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cellsGastric Cancer, 2002
- Recurrence following curative resection for gastric carcinomaBritish Journal of Surgery, 2000
- Peritoneal washing cytology: Prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resectionJournal of Surgical Oncology, 1999
- Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancerBritish Journal of Surgery, 1990